Loss-of-SIRT1 function during vascular ageing: Hyperphosphorylation mediated by cyclin-dependent kinase 5

被引:63
作者
Bai, Bo [1 ]
Vanhoutte, Paul M. [1 ]
Wang, Yu [1 ]
机构
[1] Univ Hong Kong, LKS Fac Med, Dept Pharmacol & Pharm, Pok Fu Lam, Hong Kong, Peoples R China
关键词
PROTEIN-KINASE; SIRT1; SENESCENCE; CDK5; MECHANISMS; PHOSPHORYLATION; DYSFUNCTION; ACTIVATION; PROMOTES; CALPAIN;
D O I
10.1016/j.tcm.2013.07.001
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
The longevity regulator SIRT1 is an enzyme catalyzing the deacetylation of protein substrates, in turn modulating their biological functions. In endothelial cells, downregulation of SIRT1 evokes cellular senescence. In aged arteries, SIRT1 expression and activity is blunted, which contributes to the development of atherosclerosis and abnormal vascular responses. A recent study suggests that cyclin-dependent kinase 5 (CDK5) is responsible for the phosphorylation of SIRT1 at the serine 47 residue. This modification blocks the anti-senescence activity of SIRT1 and plays a critical role in the loss-of-SIRT1 function during vascular ageing. Thus, by inhibiting CDK5, SIRT1 function can be improved, in turn preventing the development of atherosclerosis and slowing down the process of vascular ageing. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:81 / 84
页数:4
相关论文
共 46 条
[1]
Phosphorylation of HuR by Chk2 regulates SIRT1 expression [J].
Abdelmohsen, Kotb ;
Pullmann, Rudolf, Jr. ;
Lai, Ashish ;
Kim, Hyeon Ho ;
Galban, Stefanie ;
Yang, Xiaoling ;
Blethrow, Justin D. ;
Walker, Mark ;
Shubert, Jonathan ;
Gillespie, David A. ;
Furneaux, Henry ;
Gorospe, Myriam .
MOLECULAR CELL, 2007, 25 (04) :543-557
[2]
Extraneuronal activities and regulatory mechanisms of the atypical cyclin-dependent kinase Cdk5 [J].
Arif, Abul .
BIOCHEMICAL PHARMACOLOGY, 2012, 84 (08) :985-993
[3]
Bai B, 2012, METHODS MOL BIOL, V965
[4]
Cyclin-Dependent Kinase 5-Mediated Hyperphosphorylation of Sirtuin-1 Contributes to the Development of Endothelial Senescene and Atherosclerosis [J].
Bai, Bo ;
Liang, Yan ;
Xu, Cheng ;
Lee, Mary Y. K. ;
Xu, Aimin ;
Wu, Donghai ;
Vanhoutte, Paul M. ;
Wang, Yu .
CIRCULATION, 2012, 126 (06) :729-+
[5]
Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9 [J].
Berberich, Nina ;
Uhl, Bernd ;
Joore, Jos ;
Schmerwitz, Ulrike K. ;
Mayer, Bettina A. ;
Reichel, Christoph A. ;
Krombach, Fritz ;
Zahler, Stefan ;
Vollmar, Angelika M. ;
Fuerst, Robert .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (05) :1086-1098
[6]
Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine [J].
Bukanov, Nikolay O. ;
Smith, Laurie A. ;
Klinger, Katherine W. ;
Ledbetter, Steven R. ;
Ibraghimov-Beskrovnaya, Oxana .
NATURE, 2006, 444 (7121) :949-952
[7]
Chen HZ, 2013, TRENDS CARDIOVASC ME
[8]
Cyclin-Dependent Kinase 5 Phosphorylates Endothelial Nitric Oxide Synthase at Serine 116 [J].
Cho, Du-Hyong ;
Seo, Jungwon ;
Park, Jung-Hyun ;
Jo, Chulman ;
Choi, Yoon Jung ;
Soh, Jae-Won ;
Jo, Inho .
HYPERTENSION, 2010, 55 (02) :345-U242
[9]
Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation [J].
Cicero, S ;
Herrup, K .
JOURNAL OF NEUROSCIENCE, 2005, 25 (42) :9658-9668
[10]
Potent inhibitors of CDK5 derived from roscovitine: Synthesis, biological evaluation and molecular modelling [J].
Demange, Luc ;
Abdellah, Fatma Nait ;
Lozach, Olivier ;
Ferandin, Yoan ;
Gresh, Nohad ;
Meijer, Laurent ;
Galons, Herve .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (01) :125-131